AstraZeneca unveils new CFO as sales slump continues
This article was originally published in Scrip
Executive Summary
AstraZeneca has reported an ongoing slide in sales and profits in the third quarter as recent losses of exclusivity in key products continue to bite. The pharma giant also announced that it has found a replacement for CFO Simon Lowth, who leaves AstraZeneca today (31 October).